DK3737677T3 - Tetrahydroisoquinolinforbindelser - Google Patents
Tetrahydroisoquinolinforbindelser Download PDFInfo
- Publication number
- DK3737677T3 DK3737677T3 DK19700284.3T DK19700284T DK3737677T3 DK 3737677 T3 DK3737677 T3 DK 3737677T3 DK 19700284 T DK19700284 T DK 19700284T DK 3737677 T3 DK3737677 T3 DK 3737677T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydroisoquinoline compounds
- tetrahydroisoquinoline
- compounds
- Prior art date
Links
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382010 | 2018-01-10 | ||
| PCT/EP2019/050518 WO2019137985A1 (en) | 2018-01-10 | 2019-01-10 | Tetrahydroisoquinoline compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3737677T3 true DK3737677T3 (da) | 2022-01-10 |
Family
ID=62104212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19700284.3T DK3737677T3 (da) | 2018-01-10 | 2019-01-10 | Tetrahydroisoquinolinforbindelser |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11466012B2 (da) |
| EP (1) | EP3737677B1 (da) |
| JP (1) | JP2021510699A (da) |
| CN (1) | CN112262137A (da) |
| CA (1) | CA3087888A1 (da) |
| DK (1) | DK3737677T3 (da) |
| ES (1) | ES2905568T3 (da) |
| MX (1) | MX2020007403A (da) |
| RU (1) | RU2020126188A (da) |
| WO (1) | WO2019137985A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021005688A (es) | 2018-11-14 | 2021-07-07 | Allinky Biopharma | Compuestos de piridina sulfonamida para el tratamiento contra afecciones relacionadas con interleucina 1 beta. |
| EP3763711A1 (en) * | 2019-07-09 | 2021-01-13 | Allinky Biopharma | Tetrahydroisoquinoline compounds |
| IL299131A (en) | 2020-06-18 | 2023-02-01 | Revolution Medicines Inc | Methods for delaying, preventing and treating acquired resistance to RAS inhibitors |
| MX2023002248A (es) | 2020-09-03 | 2023-05-16 | Revolution Medicines Inc | Uso de inhibidores de sos1 para tratar neoplasias malignas con mutaciones de shp2. |
| CN118922418A (zh) * | 2022-03-09 | 2024-11-08 | 思路迪生物医药(上海)有限公司 | 一类作为泛-kras抑制剂的四氢异喹啉类衍生物及其制备方法和应用 |
| CN114874201B (zh) * | 2022-04-08 | 2023-01-20 | 思路迪生物医药(上海)有限公司 | 一类泛-kras抑制剂及其制备和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| NZ527276A (en) * | 2001-03-27 | 2004-11-26 | Actelion Pharmaceuticals Ltd | 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists |
| SE0303542D0 (sv) * | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | 1,2,3,4-Tetrahydroisoquinoline derivaties, preparations thereof and uses thereof |
| UA91341C2 (ru) * | 2004-07-15 | 2010-07-26 | Амр Текнолоджи, Інк. | Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина |
| BRPI0716715B1 (pt) | 2006-08-23 | 2021-07-06 | Xenon Pharmaceuticals, Inc | Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula |
| CA2703477C (en) | 2007-10-25 | 2016-10-11 | Exelixis, Inc. | Pyridinyl substituted tropane compounds and uses thereof |
| TW201100427A (en) * | 2009-03-31 | 2011-01-01 | Arqule Inc | Substituted heterocyclic compounds |
| WO2011017125A1 (en) | 2009-07-28 | 2011-02-10 | Anacor Pharmaceuticals, Inc. | Trisubstituted boron-containing molecules |
| EP3080103B9 (en) | 2013-12-11 | 2018-09-19 | Biogen MA Inc. | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology |
| WO2016033105A1 (en) * | 2014-08-29 | 2016-03-03 | The Board Of Regents Of The University Of Texas System | Novel capsazepine analogs for the treatment of cancer and other proliferative diseases |
| CN106117182B (zh) * | 2016-06-20 | 2019-08-30 | 中国药科大学 | 喹唑啉-n-苯乙基四氢异喹啉类化合物及其制备方法和应用 |
| MX2021005688A (es) | 2018-11-14 | 2021-07-07 | Allinky Biopharma | Compuestos de piridina sulfonamida para el tratamiento contra afecciones relacionadas con interleucina 1 beta. |
-
2019
- 2019-01-10 RU RU2020126188A patent/RU2020126188A/ru unknown
- 2019-01-10 WO PCT/EP2019/050518 patent/WO2019137985A1/en not_active Ceased
- 2019-01-10 ES ES19700284T patent/ES2905568T3/es active Active
- 2019-01-10 DK DK19700284.3T patent/DK3737677T3/da active
- 2019-01-10 CN CN201980018534.8A patent/CN112262137A/zh active Pending
- 2019-01-10 JP JP2020538706A patent/JP2021510699A/ja active Pending
- 2019-01-10 EP EP19700284.3A patent/EP3737677B1/en active Active
- 2019-01-10 US US16/961,190 patent/US11466012B2/en active Active
- 2019-01-10 CA CA3087888A patent/CA3087888A1/en active Pending
- 2019-01-10 MX MX2020007403A patent/MX2020007403A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3737677A1 (en) | 2020-11-18 |
| JP2021510699A (ja) | 2021-04-30 |
| US11466012B2 (en) | 2022-10-11 |
| ES2905568T3 (es) | 2022-04-11 |
| CA3087888A1 (en) | 2019-07-18 |
| WO2019137985A1 (en) | 2019-07-18 |
| RU2020126188A (ru) | 2022-02-10 |
| US20200369671A1 (en) | 2020-11-26 |
| MX2020007403A (es) | 2020-11-11 |
| CN112262137A (zh) | 2021-01-22 |
| EP3737677B1 (en) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20253006I1 (fi) | Linvoseltamabi | |
| IL283692A (en) | Novel composition | |
| FIC20260010I1 (fi) | imlunestrantti | |
| EP3890716A4 (en) | COMBINATION THERAPIES | |
| LT3810602T (lt) | Junginiai | |
| EP3846674C0 (en) | VAGINAL SPECULUM | |
| EP3849534A4 (en) | COMBINATION THERAPIES | |
| EP3555124C0 (en) | TCR NYESO | |
| DK3810587T3 (da) | Substituerede alkoxypyridinylindolsulfonamider | |
| EP3781060A4 (en) | CRYOPROBE | |
| EP3784463A4 (en) | Fluorosulfones | |
| DK3737677T3 (da) | Tetrahydroisoquinolinforbindelser | |
| EP3872558A4 (en) | OPTICAL ISOLATOR | |
| EP3810860C0 (en) | COUPLER | |
| HUE065134T2 (hu) | Vegyületek | |
| DK3808747T3 (da) | Imidazopyridinon-forbindelse | |
| EP3792200A4 (en) | TANK TANK | |
| LT3867247T (lt) | Naujieji junginiai | |
| EP3745904C0 (de) | Stockgriff | |
| EP3878374A4 (en) | Occlusion device | |
| EP3997086C0 (en) | TETRAHYDROISOQUINOLINE COMPOUNDS | |
| EP3721129A4 (en) | CRYOSPHERE | |
| HUE056928T2 (hu) | Új vegyületek | |
| EP3902806C0 (en) | THIENOPYRIDINONE COMPOUNDS | |
| EP3844177A4 (en) | COMBINATION THERAPIES |